---
figid: PMC3387977__nihms381454f3
figtitle: Targets for inhibition within the EGFR signaling pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3387977
filename: nihms381454f3.jpg
figlink: /pmc/articles/PMC3387977/figure/F3/
number: F3
caption: Potential targets for inhibition within the EGFR signaling pathway. Multiple
  points along the EGFR signaling pathway, indicated with arrows, are currently being
  evaluated as therapeutic targets in the treatment of NSCLC. Inhibition of EGFR activation
  can occur by targeting EGFR itself and/or its downstream mediators. Small molecule
  TKIs and other agents are shown associated with their respective targets. Figure
  adapted with permission from []
papertitle: 'Epidermal growth factor receptor inhibition in lung cancer: the evolving
  role of individualized therapy.'
reftext: Adi F. Gazdar. Cancer Metastasis Rev. ;29(1):37-48.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9630734
figid_alias: PMC3387977__F3
figtype: Figure
redirect_from: /figures/PMC3387977__F3
ndex: 0409932e-ded8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3387977__nihms381454f3.html
  '@type': Dataset
  description: Potential targets for inhibition within the EGFR signaling pathway.
    Multiple points along the EGFR signaling pathway, indicated with arrows, are currently
    being evaluated as therapeutic targets in the treatment of NSCLC. Inhibition of
    EGFR activation can occur by targeting EGFR itself and/or its downstream mediators.
    Small molecule TKIs and other agents are shown associated with their respective
    targets. Figure adapted with permission from []
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Stat92E
  - Akt
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - MKP-4
  - p38b
  - rl
  - Mtor
  - Tor
  - Dsor1
  - Mtk
  - TGFA
  - EGF
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - AKT1
  - AKT2
  - AKT3
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - temsirolimus
  - vandetanib
  - enzastaurin
  - PD-0325901
  - AZD6244
  - BMS-690514
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
